135 related articles for article (PubMed ID: 37874431)
1. Differential expression of TOB/BTG family members in patients with plaque psoriasis: cross-sectional study.
Barrera-Ochoa CA; Fonseca-Camarillo G; Vega-Memije ME; Furuzawa-Carballeda J; Uriarte-Ruiz K; Fernández-Camargo DA; Yamamoto-Furusho JK
Immunol Res; 2024 Apr; 72(2):234-241. PubMed ID: 37874431
[TBL] [Abstract][Full Text] [Related]
2. Expression of TOB/BTG family members in patients with inflammatory bowel disease.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Priego-Ranero ÁA; Martínez-Benítez B; Barreto-Zúñiga R; Yamamoto-Furusho JK
Scand J Immunol; 2021 Apr; 93(4):e13004. PubMed ID: 33247598
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system.
Sasajima H; Nakagawa K; Yokosawa H
Eur J Biochem; 2002 Jul; 269(14):3596-604. PubMed ID: 12135500
[TBL] [Abstract][Full Text] [Related]
4. BTG/Tob family members Tob1 and Tob2 inhibit proliferation of mouse embryonic stem cells via Id3 mRNA degradation.
Chen Y; Wang C; Wu J; Li L
Biochem Biophys Res Commun; 2015 Jul; 462(3):208-14. PubMed ID: 25951976
[TBL] [Abstract][Full Text] [Related]
5. The mammalian anti-proliferative BTG/Tob protein family.
Winkler GS
J Cell Physiol; 2010 Jan; 222(1):66-72. PubMed ID: 19746446
[TBL] [Abstract][Full Text] [Related]
6. The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex.
Doidge R; Mittal S; Aslam A; Winkler GS
PLoS One; 2012; 7(12):e51331. PubMed ID: 23236473
[TBL] [Abstract][Full Text] [Related]
7. BTG/TOB factors impact deadenylases.
Mauxion F; Chen CY; Séraphin B; Shyu AB
Trends Biochem Sci; 2009 Dec; 34(12):640-7. PubMed ID: 19828319
[TBL] [Abstract][Full Text] [Related]
8. Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes.
Park GT; Seo EY; Lee KM; Lee DY; Yang JM
Br J Dermatol; 2006 Mar; 154(3):411-8. PubMed ID: 16445768
[TBL] [Abstract][Full Text] [Related]
9. Monoubiquitination of Tob/BTG family proteins competes with degradation-targeting polyubiquitination.
Suzuki T; Kim M; Kozuka-Hata H; Watanabe M; Oyama M; Tsumoto K; Yamamoto T
Biochem Biophys Res Commun; 2011 May; 409(1):70-4. PubMed ID: 21549103
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract][Full Text] [Related]
11. Tob genes in development and homeostasis.
Jia S; Meng A
Dev Dyn; 2007 Apr; 236(4):913-21. PubMed ID: 17304515
[TBL] [Abstract][Full Text] [Related]
12. In search of a function for the TIS21/PC3/BTG1/TOB family.
Matsuda S; Rouault J; Magaud J; Berthet C
FEBS Lett; 2001 May; 497(2-3):67-72. PubMed ID: 11377414
[TBL] [Abstract][Full Text] [Related]
13. Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects.
Berthet C; Guéhenneux F; Revol V; Samarut C; Lukaszewicz A; Dehay C; Dumontet C; Magaud JP; Rouault JP
Genes Cells; 2002 Jan; 7(1):29-39. PubMed ID: 11856371
[TBL] [Abstract][Full Text] [Related]
14. Regulation of subcellular localization of the antiproliferative protein Tob by its nuclear export signal and bipartite nuclear localization signal sequences.
Maekawa M; Yamamoto T; Nishida E
Exp Cell Res; 2004 Apr; 295(1):59-65. PubMed ID: 15051490
[TBL] [Abstract][Full Text] [Related]
15. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage.
Cortes U; Moyret-Lalle C; Falette N; Duriez C; Ghissassi FE; Barnas C; Morel AP; Hainaut P; Magaud JP; Puisieux A
Mol Carcinog; 2000 Feb; 27(2):57-64. PubMed ID: 10657898
[TBL] [Abstract][Full Text] [Related]
16. TOB1 Blocks Intestinal Mucosal Inflammation Through Inducing ID2-Mediated Suppression of Th1/Th17 Cell Immune Responses in IBD.
Lin R; Ma C; Fang L; Xu C; Zhang C; Wu X; Wu W; Zhu R; Cong Y; Liu Z
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1201-1221. PubMed ID: 34920145
[TBL] [Abstract][Full Text] [Related]
17. Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer.
Iwanaga K; Sueoka N; Sato A; Sakuragi T; Sakao Y; Tominaga M; Suzuki T; Yoshida Y; K-Tsuzuku J; Yamamoto T; Hayashi S; Nagasawa K; Sueoka E
Cancer Lett; 2003 Dec; 202(1):71-9. PubMed ID: 14643028
[TBL] [Abstract][Full Text] [Related]
18. Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1) through modulation of the MAPK/ERK pathway.
Sun KK; Zhong N; Yang Y; Zhao L; Jiao Y
Oncol Rep; 2013 Jun; 29(6):2385-91. PubMed ID: 23589165
[TBL] [Abstract][Full Text] [Related]
19. TOB1 and TOB2 mark distinct RNA processing granules in differentiating lens fiber cells.
Perez RC; Yang X; Familari M; Martinez G; Lovicu FJ; Hime GR; de Iongh RU
J Mol Histol; 2024 Feb; 55(1):121-138. PubMed ID: 38165569
[TBL] [Abstract][Full Text] [Related]
20. Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing βTrCP.
Sasajima H; Nakagawa K; Kashiwayanagi M; Yokosawa H
Biol Pharm Bull; 2012; 35(9):1539-45. PubMed ID: 22975506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
